Novita Healthcare (NHL) Stock Price, News & Analysis

Company Overview

Novita Healthcare Limited engages in the development and commercialization of healthcare technologies in Australia. The company operates through Research and Development, Healthcare/Workforce Management, and Investments segments. It offers TALI Train, a game-based training program to treat and monitor cognitive problems, such as attention difficulties in early childhood. The company also develops a technology solution for care or support professionals looking for employment, as well as for aged care or disability support providers needing staff. In addition, it primarily invests in Australian equities. The company was formerly known as Avexa Limited and changed its name to Novita Healthcare Limited in December 2016. Novita Healthcare Limited was founded in 2004 and is based in Glen Iris, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 8.20 million shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NHL Stock Analysis - Frequently Asked Questions

How were Novita Healthcare's earnings last quarter?

Novita Healthcare Ltd (ASX:NHL) announced its quarterly earnings results on Tuesday, February, 26th. The company reported $0.00 earnings per share (EPS) for the quarter.

Company Calendar

• Last Earnings: 2/26/2019
• Today: 7/14/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Computer and Technology
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: ASX:NHL
• CIK: N/A
• Web: www.novitahealthcare.com.au
• Phone: 61 3 9192 9937
• Fax: N/A
• Employees: 13
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 749,305,024
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A